Cian Healthcare has informed about disclosure made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) by Cian Healthcare (Company); and Update on the receipt of the Trading approval for the 2,50,00,000 (Two Crores Fifty Lakhs) fully paid-up equity shares, from the BSE (Stock Exchange or BSE) pursuant to the approved Resolution Plan read with the Order of the Hon’ble National Company Law Tribunal (NCLT) dated December 18, 2025 (NCLT Order) and further details of which are mentioned hereunder: Trading approval for the 12,50,000 (Twelve Lakhs Fifty Thousand) fully paid-up equity shares at a face value of INR 10 (Indian Rupees Ten Only) each, to the public shareholder; and Trading approval for the 2,37,50,000 (Two Crores Thirty-Seven Lakhs Fifty Thousand) fully paid-up equity shares at a face value of INR 10 (Indian Rupees Ten Only) each, to the promoters.

The above information is a part of company’s filings submitted to BSE.